Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Swiss pharma giant Novartis posts better-than-expected fourth-quarter sales
CNBC
Friday, January 31, 2025 - 11:13am
tags:
Novartis, earnings
Is federal funding frozen? Has it already thawed? Flip-flop leaves biopharma on edge
Pharma Voice
Friday, January 31, 2025 - 11:10am
tags:
NIH, R&D, federal funding, funding, Donald Trump
Review confirms that antidepressants reduce anxiety, but long-term impact remains unclear
Medical Xpress
Friday, January 31, 2025 - 11:08am
tags:
anxiety, antidepressants, generalized anxiety disorder
AstraZeneca abandons plan for £450m vaccine plant in UK
Pharmaphorum
Friday, January 31, 2025 - 11:07am
tags:
AstraZeneca, vaccines, UK, drug manufacturing
Metsera, Maze secure combined $415 million in IPOs
BioPharma Dive
Friday, January 31, 2025 - 11:05am
tags:
Metsera, Maze Therapeutics, IPOs, biotech
Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say
Forbes
Friday, January 31, 2025 - 10:59am
tags:
surgery, GLP-1 agonists, Novo Nordisk, Eli Lilly, Ozempic, Wegovy, Zepbound, Mounjaro
Vertex’s non-opioid pain drug gets FDA approval in milestone for company and research
BioPharma Dive
Thursday, January 30, 2025 - 11:36pm
tags:
Vertex Pharmaceuticals, non-opioid pain treatments, FDA, Journavx
FDA Approves Axsome Therapeutics’ AXS-07 for Migraine Treatment
Neurology Live
Thursday, January 30, 2025 - 11:33pm
tags:
Axsome Therapeutics, AXS-07, migraines, FDA
RFK Jr. fumbles Medicare basics during second confirmation hearing
BioPharma Dive
Thursday, January 30, 2025 - 11:32pm
tags:
Robert F Kennedy Jr., HHS, Senate, Medicare
Vabysmo crosses $4B mark, Polivy joins blockbuster club as Roche preps for key readouts
Fierce Pharma
Thursday, January 30, 2025 - 11:30pm
tags:
Roche, Polivy, Vabysmo, earnings
Regeneron patents block biosimilar entry for Eylea
Patently-O
Thursday, January 30, 2025 - 11:26pm
tags:
Regeneron, Eylea, legal, biosimilars, patents
Novartis to Make Super Bowl 2025 Debut with Breast Cancer Commercial
Xtalks
Thursday, January 30, 2025 - 11:24pm
tags:
Novartis, breast cancer, Super Bowl, DTC advertising, television ads
Novo Nordisk commences fresh trials for CagriSema
Devdiscourse
Thursday, January 30, 2025 - 11:33am
tags:
Novo Nordisk, CagriSema, clinical trials, obesity
Express Scripts becomes latest PBM to follow in Mark Cuban's footsteps
Beckers Hospital Review
Thursday, January 30, 2025 - 11:28am
tags:
PBMs, Express Scripts, Mark Cuban
FDA protocol deviation guidance could go further
Clinical Trials Arena
Thursday, January 30, 2025 - 11:05am
tags:
FDA, clinical trials, regulatory
Imvax secures $29m to support Phase IIb glioblastoma therapy trial
Clinical Trials Arena
Thursday, January 30, 2025 - 11:03am
tags:
Imvax, IGV-001, glioblastoma, clinical trials, funding
With efficacy assured, Merck halts another trial of blockbuster-to-be Winrevair
Fierce Pharma
Thursday, January 30, 2025 - 10:58am
tags:
Merck, clinical trials, Winrevair, PAH
Sanofi Plans €5 Billion Buyback, Sees Higher Profit Growth
Yahoo/Bloomberg
Thursday, January 30, 2025 - 10:55am
tags:
Sanofi, earnings
Shionogi's RSV antiviral reduces viral load in phase 2 trial of adults
Fierce Biotech
Thursday, January 30, 2025 - 10:53am
tags:
Shionogi, RSV, clinical trials, S-337395
ImmunityBio and BeiGene partner on Phase III trial of NSCLC treatment combo
Clinical Trials Arena
Thursday, January 30, 2025 - 10:52am
tags:
ImmunityBio, BeiGene, clinical trials, tislelizumab, anktiva, advanced non-small cell lung cancer, metastatic non-small cell lung cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.